- cafead Feb 08, 2020 at 12:02: AM
via Myriad Genetics (NASDAQ: MYGN) announced on Thursday that its Chief Executive Officer, Mark Capone, was resigning. Capone served as CEO since 2015 and was with the company for 17 years. CFO Bryan Riggsbee was named interim CEO.
article source
article source